As a 503B outsourcing facility, OurPharma is alleviating the impacts of drug shortages on healthcare organizations. They have the resources, supplies, and staff with extensive hospital and healthcare administration backgrounds who understand the difficulties caused by drug shortages and their effects on patients.
Clients can turn to OurPharma for trusted, reliable, compounded pharmaceuticals. A snapshot of OurPharma credentials provides ample evidence of why pharmaceutical leaders to them:
• 24,000 ft² cGMP-compliant, state-of-the-art 503B outsourcing facility
• DEA and FDA-registered
• Leading edge cleanroom design adjusted for unidirectional workflow and segregation of processing
• Continuous cleanroom monitoring for temperature, humidity, particles, and differential pressures
o ULPA (Ultra Low Particle Air) filters with a 99.9995% efficiency removing 0.12 microns and larger
o Optimized HVAC system with UV light technology
OurPharma bridges the gap between 503B compounding facilities and large pharmaceutical manufacturers, maintaining the strict standards expected from both. The bottom line, there is an average shortage of more than 200 medications daily, OurPharma addresses this problem.
This post is related to:
Admixture Compounding Services (503B Outsourcing Facilities)